Estrategias Combinadas en Inmunoterapia Traslacional
ITC
![Foto de Estrategias Combinadas en Inmunoterapia Traslacional](/img/uploaded/479403294d9802387805dfa0a2918bd0.jpg)
![Foto de University of Washington School of Medicine](/img/noimage_org.png)
University of Washington School of Medicine
Seattle, Estados UnidosUniversity of Washington School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2017
-
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
The Lancet, Vol. 389, Núm. 10064, pp. 67-76